2017 Form 10-K Financial Statement
#000114420418011197 Filed on February 27, 2018
Income Statement
| Concept | 2017 | 2016 Q4 | 2016 Q3 |
|---|---|---|---|
| Revenue | $176.8M | $38.21M | $38.53M |
| YoY Change | 37.49% | 111.84% | 92.9% |
| Cost Of Revenue | $79.03M | $16.91M | $16.67M |
| YoY Change | 62.02% | 377.68% | 411.32% |
| Gross Profit | $97.81M | $21.30M | $21.86M |
| YoY Change | 22.5% | 46.9% | 30.78% |
| Gross Profit Margin | 55.31% | 55.75% | 56.73% |
| Selling, General & Admin | $31.58M | $7.370M | $6.928M |
| YoY Change | 13.48% | 34.98% | 28.32% |
| % of Gross Profit | 32.29% | 34.6% | 31.7% |
| Research & Development | $9.070M | $140.0K | $1.041M |
| YoY Change | 212.11% | -78.79% | 27.73% |
| % of Gross Profit | 9.27% | 0.66% | 4.76% |
| Depreciation & Amortization | $27.93M | $5.810M | $5.966M |
| YoY Change | 25.0% | 175.36% | 191.45% |
| % of Gross Profit | 28.55% | 27.28% | 27.3% |
| Operating Expenses | $40.65M | $13.31M | $7.969M |
| YoY Change | 32.26% | 61.73% | 28.24% |
| Operating Profit | $28.33M | $1.298M | $7.921M |
| YoY Change | 41.09% | -79.29% | -6.27% |
| Interest Expense | -$12.04M | -$2.860M | -$2.856M |
| YoY Change | 6.25% | 3.25% | 3.25% |
| % of Operating Profit | -42.48% | -220.34% | -36.06% |
| Other Income/Expense, Net | $55.00K | -$40.00K | -$21.00K |
| YoY Change | -174.32% | -25.0% | |
| Pretax Income | $16.35M | -$1.600M | $5.044M |
| YoY Change | 88.4% | -145.71% | -10.84% |
| Income Tax | $17.43M | $524.0K | -$2.501M |
| % Of Pretax Income | 106.58% | -49.58% | |
| Net Earnings | -$1.076M | -$1.080M | $2.543M |
| YoY Change | -127.35% | -137.5% | -44.22% |
| Net Earnings / Revenue | -0.61% | -2.83% | 6.6% |
| Basic Earnings Per Share | -$0.09 | -$0.09 | $0.22 |
| Diluted Earnings Per Share | -$0.09 | -$0.09 | $0.22 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 11.55M | 11.47M shares | |
| Diluted Shares Outstanding | 11.55M | 11.63M shares |
Balance Sheet
| Concept | 2017 | 2016 Q4 | 2016 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $31.10M | $27.40M | $16.20M |
| YoY Change | 13.5% | -82.29% | -89.26% |
| Cash & Equivalents | $31.10M | $27.37M | $16.16M |
| Short-Term Investments | |||
| Other Short-Term Assets | $2.800M | $3.600M | $2.700M |
| YoY Change | -22.22% | 140.0% | -73.79% |
| Inventory | $37.70M | $26.18M | $28.30M |
| Prepaid Expenses | $3.564M | ||
| Receivables | $58.80M | $45.90M | $47.50M |
| Other Receivables | $1.200M | $0.00 | $900.0K |
| Total Short-Term Assets | $131.6M | $103.0M | $95.50M |
| YoY Change | 27.77% | -46.51% | -51.65% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $20.40M | $11.00M | $9.700M |
| YoY Change | 85.45% | 54.23% | 66.3% |
| Goodwill | $1.838M | ||
| YoY Change | 0.0% | ||
| Intangibles | $175.8M | ||
| YoY Change | 164.76% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $28.50M | $0.00 | $23.40M |
| YoY Change | -8.65% | -100.0% | 138.78% |
| Total Long-Term Assets | $280.5M | $219.9M | $223.9M |
| YoY Change | 27.56% | 137.22% | 161.02% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $131.6M | $103.0M | $95.50M |
| Total Long-Term Assets | $280.5M | $219.9M | $223.9M |
| Total Assets | $412.1M | $322.9M | $319.4M |
| YoY Change | 27.62% | 13.18% | 12.74% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.600M | $3.389M | $4.700M |
| YoY Change | 5.88% | 64.04% | 80.77% |
| Accrued Expenses | $24.00M | $927.0K | $21.70M |
| YoY Change | 17.65% | 50.24% | 877.04% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $3.400M | $0.00 | |
| YoY Change | |||
| Total Short-Term Liabilities | $39.20M | $31.95M | $30.50M |
| YoY Change | 22.88% | 171.76% | 150.21% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $198.2M | $0.00 | $118.8M |
| YoY Change | 64.34% | -100.0% | 3.13% |
| Other Long-Term Liabilities | $0.00 | $600.0K | $1.300M |
| YoY Change | -100.0% | ||
| Total Long-Term Liabilities | $198.2M | $0.00 | $120.1M |
| YoY Change | 63.53% | -100.0% | 4.25% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $39.20M | $31.95M | $30.50M |
| Total Long-Term Liabilities | $198.2M | $0.00 | $120.1M |
| Total Liabilities | $237.4M | $153.2M | $150.5M |
| YoY Change | 54.96% | 22.39% | 18.15% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$2.916M | ||
| YoY Change | -32.97% | ||
| Common Stock | $1.000K | ||
| YoY Change | 0.0% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $174.8M | $169.6M | $168.8M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $412.1M | $322.9M | $319.4M |
| YoY Change | 27.62% | 13.18% | 12.75% |
Cashflow Statement
| Concept | 2017 | 2016 Q4 | 2016 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.076M | -$1.080M | $2.543M |
| YoY Change | -127.35% | -137.5% | -44.22% |
| Depreciation, Depletion And Amortization | $27.93M | $5.810M | $5.966M |
| YoY Change | 25.0% | 175.36% | 191.45% |
| Cash From Operating Activities | $39.42M | $12.08M | $1.080M |
| YoY Change | 43.49% | 157.02% | -89.44% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $10.37M | -$1.390M | -$1.090M |
| YoY Change | 127.09% | 26.36% | 41.56% |
| Acquisitions | $0.00 | ||
| YoY Change | |||
| Other Investing Activities | -$97.62M | $0.00 | $0.00 |
| YoY Change | -32.44% | -100.0% | |
| Cash From Investing Activities | -$108.0M | -$1.390M | -$1.090M |
| YoY Change | -27.55% | 26.36% | -95.93% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | ||
| YoY Change | -100.0% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 72.36M | 520.0K | 1.140M |
| YoY Change | -10025.51% | 188.89% | 60.56% |
| NET CHANGE | |||
| Cash From Operating Activities | 39.42M | 12.08M | 1.080M |
| Cash From Investing Activities | -108.0M | -1.390M | -1.090M |
| Cash From Financing Activities | 72.36M | 520.0K | 1.140M |
| Net Change In Cash | 3.783M | 11.21M | 1.130M |
| YoY Change | -103.09% | 196.56% | -107.14% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $39.42M | $12.08M | $1.080M |
| Capital Expenditures | $10.37M | -$1.390M | -$1.090M |
| Free Cash Flow | $29.05M | $13.47M | $2.170M |
| YoY Change | 26.82% | 132.24% | -80.27% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
48780000 | USD |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2906000 | USD |
| CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1571000 | USD |
| CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
927000 | USD |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2306000 | USD |
| CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1631000 | USD |
| CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
5006000 | USD |
| CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
5002000 | USD |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
625000 | USD |
| CY2017Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
2398000 | USD |
| CY2017Q4 | anip |
Accrued Government Rebates
AccruedGovernmentRebates
|
7930000 | USD |
| CY2016Q4 | anip |
Accrued Government Rebates
AccruedGovernmentRebates
|
5891000 | USD |
| CY2017Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
1162000 | USD |
| CY2016Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
0 | USD |
| CY2017Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
259000 | USD |
| CY2016Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
0 | USD |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2016 | us-gaap |
Revenues
Revenues
|
128622000 | USD |
| CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
27829000 | USD |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
20079000 | USD |
| CY2016 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-11327000 | USD |
| CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
55000 | USD |
| CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-74000 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
8678000 | USD |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4744000 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1076000 | USD |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3934000 | USD |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
| CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.34 | |
| CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
| CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.34 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11547000 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11445000 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11547000 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11573000 | shares |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6090000 | USD |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6067000 | USD |
| CY2017 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
7666000 | USD |
| CY2016 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
7281000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
12893000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
23963000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-5356000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1938000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
17000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
647000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1076000 | USD |
| CY2017 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
675000 | USD |
| CY2016 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
443000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
|
-3560000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
|
3525000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
644000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
940000 | USD |
| CY2017 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
97624000 | USD |
| CY2016 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
144494000 | USD |
| CY2017 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
2737000 | USD |
| CY2016 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
294000 | USD |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10369000 | USD |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4566000 | USD |
| CY2017 | anip |
Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
|
259000 | USD |
| CY2016 | anip |
Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
|
122000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
143750000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
13924000 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
128208000 | USD |
| CY2016Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
143750000 | USD |
| CY2016Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
20644000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
120643000 | USD |
| CY2017Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1618000 | USD |
| CY2016Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
2463000 | USD |
| CY2016 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6372000 | USD |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
353000 | USD |
| CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1570000 | USD |
| CY2017 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
0 | USD |
| CY2016 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
617000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
39419000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
27472000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-107993000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-149060000 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
72357000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-729000 | USD |
| CY2017 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2016 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
2500000 | USD |
| CY2017 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
-417000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
6269000 | USD |
| CY2017 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
3560000 | USD |
| CY2016 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-8911000 | USD |
| CY2017 | anip |
Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
|
2518000 | USD |
| CY2016 | anip |
Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
|
3108000 | USD |
| CY2017 | anip |
Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
|
2039000 | USD |
| CY2016 | anip |
Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
|
1260000 | USD |
| CY2017 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
75000000 | USD |
| CY2016 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
| CY2015 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
4312000 | USD |
| CY2015 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6043000 | USD |
| CY2015 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
844000 | USD |
| CY2015 | us-gaap |
Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
|
56000 | USD |
| CY2017Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
22139000 | USD |
| CY2016Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
14138000 | USD |
| CY2017Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
1527000 | USD |
| CY2016Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
930000 | USD |
| CY2017Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
350000 | USD |
| CY2016Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
174000 | USD |
| CY2017Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
510000 | USD |
| CY2017 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
845000 | USD |
| CY2016 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
844000 | USD |
| CY2017 | us-gaap |
Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
|
554000 | USD |
| CY2016 | us-gaap |
Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
|
234000 | USD |
| CY2017 | us-gaap |
Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
|
0.15 | pure |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6589000 | USD |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
5387000 | USD |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
1200000 | USD |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
900000 | USD |
| CY2015 | us-gaap |
Depreciation
Depreciation
|
700000 | USD |
| CY2017 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
600000 | USD |
| CY2016 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
200000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
229790000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
31492000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
31010000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
29564000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
26158000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
80074000 | USD |
| CY2016Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
477000 | USD |
| CY2017Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
13901000 | USD |
| CY2016Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
10812000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
31492000 | USD |
| CY2017 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
26700000 | USD |
| CY2015 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
6200000 | USD |
| CY2016 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
21400000 | USD |
| CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
34686000 | USD |
| CY2016Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
31535000 | USD |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2017 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Organization and Business</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> ANI Pharmaceuticals, Inc. and its consolidated subsidiaries (together, “ANI,” the “Company,” “we,” “us,” or “our”) is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. ANI was organized as a Delaware corporation in April 2001. At our two facilities located in Baudette, Minnesota, we manufacture oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. We also perform contract manufacturing for other pharmaceutical companies.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> On June 19, 2013, BioSante Pharmaceuticals, Inc. (“BioSante”) acquired ANIP Acquisition Company (“ANIP”) in an all-stock, tax-free reorganization (the “Merger”), in which ANIP became a wholly-owned subsidiary of BioSante. BioSante was renamed ANI Pharmaceuticals, Inc. The Merger was accounted for as a reverse acquisition pursuant to which ANIP was considered the acquiring entity for accounting purposes.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Our operations are subject to certain risks and uncertainties including, among others, current and potential competitors with greater resources, dependence on significant customers, and possible fluctuations in financial results. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The propriety of using the going-concern basis is dependent upon, among other things, the achievement of future profitable operations, the ability to generate sufficient cash from operations, and potential other funding sources, including cash on hand, to meet our obligations as they become due. We believe the going-concern basis is appropriate for the accompanying consolidated financial statements based on our current operating plan and business strategy for the 12 months following the issuance of this report.</div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, deferred tax assets and liabilities, deferred tax valuation allowance, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Credit Concentration</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Our customers are primarily wholesale distributors, chain drug stores, group purchasing organizations, and other pharmaceutical companies.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> During the year ended December 31, 2017, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 29</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 29</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>% of net revenues, respectively. As of December 31, 2017, accounts receivable from these customers totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 85</font>% of net accounts receivable. During the year ended December 31, 2016, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 28</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 22</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>% of net revenues, respectively. During the year ended December 31, 2015, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 26</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>% of net revenues, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2874000 | USD |
| CY2015 | us-gaap |
Revenues
Revenues
|
76322000 | USD |
| CY2015 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
12692000 | USD |
| CY2015 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
21156000 | USD |
| CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
6900000 | USD |
| CY2017 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
903000 | USD |
| CY2016 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
6685000 | USD |
| CY2015 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | USD |
| CY2015 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
43622000 | USD |
| CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11370000 | shares |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
32700000 | USD |
| CY2015 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-11008000 | USD |
| CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
41000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
21733000 | USD |
| CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
6358000 | USD |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15375000 | USD |
| CY2015 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.34 | |
| CY2015 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.32 | |
| CY2015 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
314000 | USD |
| CY2015 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11557000 | shares |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1027000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
-96000 | USD |
| CY2015 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
-160000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
|
-5380000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
139785000 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3856000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
819000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
360000 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
160082000 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6067000 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1570000 | USD |
| CY2016 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
2500000 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
617000 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6090000 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
353000 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3856000 | USD |
| CY2015 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-1877000 | USD |
| CY2015 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
6831000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4635000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
5869000 | USD |
| CY2015 | anip |
Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
|
2367000 | USD |
| CY2017 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1076000 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
3934000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
15375000 | USD |
| CY2015 | anip |
Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
|
1203000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
90000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
17264000 | USD |
| CY2015 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
30500000 | USD |
| CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2183000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-32683000 | USD |
| CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1076000 | USD |
| CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
3913000 | USD |
| CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
15290000 | USD |
| CY2015 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
3913000 | USD |
| CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
15291000 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
| CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-1076000 | USD |
| CY2015 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
819000 | USD |
| CY2015 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
360000 | USD |
| CY2015 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2015 | anip |
Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
|
113000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1066000 | USD |
| CY2017 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
11324000 | USD |
| CY2016 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
11294000 | USD |
| CY2015 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
11143000 | USD |
| CY2017Q4 | us-gaap |
Inventory Gross
InventoryGross
|
38077000 | USD |
| CY2016Q4 | us-gaap |
Inventory Gross
InventoryGross
|
26357000 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
26992000 | USD |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
16385000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
284716000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
203992000 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
54926000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
28200000 | USD |
| CY2016Q4 | us-gaap |
Revenues
Revenues
|
38205000 | USD |
| CY2016Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
14889000 | USD |
| CY2016Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
26143000 | USD |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-523000 | USD |
| CY2017Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1269000 | USD |
| CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1654000 | USD |
| CY2017Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-13979000 | USD |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6022000 | USD |
| CY2017Q4 | us-gaap |
Revenues
Revenues
|
47286000 | USD |
| CY2017Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
39907000 | USD |
| CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
7379000 | USD |
| CY2017Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-9629000 | USD |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.41 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.83 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.40 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.83 | |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6042000 | USD |
| CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3856000 | USD |
| CY2016Q1 | us-gaap |
Revenues
Revenues
|
20555000 | USD |
| CY2016Q2 | us-gaap |
Revenues
Revenues
|
31337000 | USD |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
38525000 | USD |
| CY2016Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
30604000 | USD |
| CY2016Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
36907000 | USD |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5666000 | USD |
| CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5194000 | USD |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
7921000 | USD |
| CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1298000 | USD |
| CY2016Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1540000 | USD |
| CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1227000 | USD |
| CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-2501000 | USD |
| CY2016Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
524000 | USD |
| CY2016Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
1346000 | USD |
| CY2016Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
1125000 | USD |
| CY2016Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
2543000 | USD |
| CY2016Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1080000 | USD |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.12 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.10 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.22 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.12 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.10 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.22 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
| CY2017 | anip |
Acquired Finitelived Intangible Asset Amortization Description
AcquiredFinitelivedIntangibleAssetAmortizationDescription
|
we are amortizing 80% of the value of the intangible assets over the first five years of useful lives of the assets and amortizing the remaining 20% of the value of the intangible assets over the second five years of useful lives of the assets. | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2017 | anip |
Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
|
less than 1% | |
| CY2016 | anip |
Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
|
less than 1% | |
| CY2015 | anip |
Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
|
less than 1% | |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
13175000 | USD |
| CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
11717000 | USD |
| CY2015 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
7264000 | USD |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
690000 | USD |
| CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1321000 | USD |
| CY2015 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
611000 | USD |
| CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
13865000 | USD |
| CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
13038000 | USD |
| CY2015 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
7875000 | USD |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
4065000 | USD |
| CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-8387000 | USD |
| CY2015 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-1468000 | USD |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-556000 | USD |
| CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-658000 | USD |
| CY2015 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-409000 | USD |
| CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
3509000 | USD |
| CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-9045000 | USD |
| CY2015 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1877000 | USD |
| CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-51000 | USD |
| CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-134000 | USD |
| CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
0 | USD |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.043 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.014 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.035 | pure |
| CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
1.066 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.547 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.293 | pure |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
5254000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
3002000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
|
5617000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
|
10921000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
|
4927000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
|
7137000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
857000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1255000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
6355000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
6302000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3029000 | USD |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.020 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.021 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.021 | pure |
| CY2017 | anip |
Effective Income Tax Rate Reconciliation Nondeductible Expense Foreign Expenses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseForeignExpenses
|
0 | pure |
| CY2016 | anip |
Effective Income Tax Rate Reconciliation Nondeductible Expense Foreign Expenses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseForeignExpenses
|
0.233 | pure |
| CY2015 | anip |
Effective Income Tax Rate Reconciliation Nondeductible Expense Foreign Expenses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseForeignExpenses
|
0 | pure |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.088 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.144 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.053 | pure |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.016 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0 | pure |
| CY2017 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost No Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostNoWindfallTaxBenefitPercent
|
0.010 | pure |
| CY2016 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost No Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostNoWindfallTaxBenefitPercent
|
0.057 | pure |
| CY2015 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost No Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostNoWindfallTaxBenefitPercent
|
0.011 | pure |
| CY2017 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost With Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostWithWindfallTaxBenefitPercent
|
-0.002 | pure |
| CY2016 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost With Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostWithWindfallTaxBenefitPercent
|
0 | pure |
| CY2015 | anip |
Effective Income Tax Rate Reconciliation Share Based Compensation Cost With Windfall Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationCostWithWindfallTaxBenefitPercent
|
-0.001 | pure |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5095000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
3030000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1680000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
29069000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
35392000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
1110000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
857000 | USD |
| CY2017Q4 | anip |
Deferred Tax Liabilities Debt Discount
DeferredTaxLiabilitiesDebtDiscount
|
3256000 | USD |
| CY2016Q4 | anip |
Deferred Tax Liabilities Debt Discount
DeferredTaxLiabilitiesDebtDiscount
|
7664000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
11000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
353000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
1699000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
16000 | USD |
| CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
6076000 | USD |
| CY2016Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
8890000 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
63000 | shares |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
326000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
275000 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
22667000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
26227000 | USD |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
0 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
42.72 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
45.72 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
48.34 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P2Y2M12D | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P2Y7M6D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
19.34 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P2Y2M12D | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P2Y7M6D | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.819 | pure |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | pure |
| CY2017Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
12900000 | USD |
| CY2017 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
approximately $0.8 million per year. | |
| CY2017 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
13400000 | USD |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
829000 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
28000 | shares |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
38000 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
50000 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
23000 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
28000 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
5000 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
0 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
63000 | shares |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
63000 | shares |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
86000 | shares |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
30000 | shares |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
8000 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
67.26 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
40.59 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
49.51 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
15.82 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
33.89 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
44.49 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
19.41 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
46.05 | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
0 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3353000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | USD |
| CY2017Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
69946000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
0 | USD |
| CY2017Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
5203 | shares |
| CY2016Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
0 | shares |
| CY2017 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
600000 | USD |
| CY2016 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
1000000 | USD |
| CY2015 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
400000 | USD |
| CY2017 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3783000 | USD |
| CY2017Q4 | anip |
Fdic Guaranteed Amount
FdicGuaranteedAmount
|
250000 | USD |
| CY2017Q4 | anip |
Chargebacks And Other Accruals As Percent Of Gross Revenue
ChargebacksAndOtherAccrualsAsPercentOfGrossRevenue
|
0.5 | pure |
| CY2017Q4 | us-gaap |
Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
|
0.030 | pure |
| CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4800000 | shares |
| CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4500000 | shares |
| CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4500000 | shares |
| CY2017 | us-gaap |
Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
|
no greater than 3.75 to 1.00, a maximum senior secured leverage ratio, which initially shall be no greater than 2.50 to 1.00, and a minimum fixed charge coverage ratio, which shall be greater than or equal to 1.25 to 1.00. | |
| CY2017Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
200000 | USD |
| CY2017Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.079 | pure |
| CY2016Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.079 | pure |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
154684000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
169037000 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
0 | USD |
| CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3759000 | USD |
| CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
4078000 | USD |
| CY2015 | us-gaap |
Interest Paid Net
InterestPaidNet
|
4149000 | USD |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
17786000 | USD |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
9537000 | USD |
| CY2015 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
13255000 | USD |
| CY2017 | anip |
Accrued Royalties Related To Asset Purchase
AccruedRoyaltiesRelatedToAssetPurchase
|
0 | USD |
| CY2016 | anip |
Accrued Royalties Related To Asset Purchase
AccruedRoyaltiesRelatedToAssetPurchase
|
3882000 | USD |
| CY2015 | anip |
Accrued Royalties Related To Asset Purchase
AccruedRoyaltiesRelatedToAssetPurchase
|
0 | USD |
| CY2017 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
485000 | USD |
| CY2016 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
247000 | USD |
| CY2015 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
439000 | USD |
| CY2017Q1 | anip |
Asset Acquisition Purchase Price
AssetAcquisitionPurchasePrice
|
30600000 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
30600000 | USD |
| CY2017Q4 | anip |
Asset Purchase Contingent Consideration Non Probable
AssetPurchaseContingentConsiderationNonProbable
|
3000000 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
30000000 | USD |
| CY2016 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-122317000 | USD |
| CY2015 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-14353000 | USD |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
36150000 | USD |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
32367000 | USD |
| CY2015Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
154684000 | USD |
| CY2014Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
169037000 | USD |
| CY2017Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
1300000 | USD |
| CY2015 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
113000 | USD |
| CY2016 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
122000 | USD |
| CY2017 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
259000 | USD |
| CY2016Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
900000 | USD |
| CY2016Q4 | us-gaap |
New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
|
0 | USD |
| CY2017Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
40000000 | USD |
| CY2017 | us-gaap |
Short Term Debt Refinanced Amount
ShortTermDebtRefinancedAmount
|
25000000 | USD |
| CY2017Q4 | us-gaap |
Short Term Debt Refinanced Amount
ShortTermDebtRefinancedAmount
|
25000000 | USD |
